Trial Profile
Dalfampridine to Improve Imbalance in Multiple Sclerosis: A Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2014
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 14 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Mar 2013 Planned End Date changed from 1 Feb 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 26 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.